A citation-based method for searching scientific literature

Jonathan J Keats, Rafael Fonseca, Marta Chesi, Roelandt Schop, Angela Baker, Wee-Joo Chng, Scott Van Wier, Rodger Tiedemann, Chang-Xin Shi, Michael Sebag, Esteban Braggio, Travis Henry, Yuan-Xiao Zhu, Homer Fogle, Tammy Price-Troska, Gregory Ahmann, Catherine Mancini, Leslie A Brents, Shaji Kumar, Philip Greipp, Angela Dispenzieri, Barb Bryant, George Mulligan, Laurakay Bruhn, Michael Barrett, Riccardo Valdez, Jeff Trent, A Keith Stewart, John Carpten, P Leif Bergsagel. Cancer Cell 2007
Times Cited: 775







List of co-cited articles
1101 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Christina M Annunziata, R Eric Davis, Yulia Demchenko, William Bellamy, Ana Gabrea, Fenghuang Zhan, Georg Lenz, Ichiro Hanamura, George Wright, Wenming Xiao,[...]. Cancer Cell 2007
731
50

Initial genome sequencing and analysis of multiple myeloma.
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, Kristian Cibulskis, Carrie Sougnez, Anna C Schinzel, Christina L Harview, Jean-Philippe Brunet, Gregory J Ahmann, Mazhar Adli,[...]. Nature 2011
18

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Brian A Walker, Eileen M Boyle, Christopher P Wardell, Alex Murison, Dil B Begum, Nasrin M Dahir, Paula Z Proszek, David C Johnson, Martin F Kaiser, Lorenzo Melchor,[...]. J Clin Oncol 2015
364
17

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, T Cody Ashby, Michael Bauer, Faith E Davies, Adam Rosenthal, Hongwei Wang, Pingping Qu, Antje Hoering,[...]. Blood 2018
227
16

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Jens G Lohr, Petar Stojanov, Scott L Carter, Peter Cruz-Gordillo, Michael S Lawrence, Daniel Auclair, Carrie Sougnez, Birgit Knoechel, Joshua Gould, Gordon Saksena,[...]. Cancer Cell 2014
681
15

Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
Yulia N Demchenko, Oleg K Glebov, Adriana Zingone, Jonathan J Keats, P Leif Bergsagel, W Michael Kuehl. Blood 2010
200
15

Genomic complexity of multiple myeloma and its clinical implications.
Salomon Manier, Karma Z Salem, Jihye Park, Dan A Landau, Gad Getz, Irene M Ghobrial. Nat Rev Clin Oncol 2017
274
14

Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Sivakumar Vallabhapurapu, Atsushi Matsuzawa, Weizhou Zhang, Ping-Hui Tseng, Jonathan J Keats, Haopeng Wang, Dario A A Vignali, P Leif Bergsagel, Michael Karin. Nat Immunol 2008
471
13

The genetic architecture of multiple myeloma.
Gareth J Morgan, Brian A Walker, Faith E Davies. Nat Rev Cancer 2012
591
12

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Niccolo Bolli, Hervé Avet-Loiseau, David C Wedge, Peter Van Loo, Ludmil B Alexandrov, Inigo Martincorena, Kevin J Dawson, Francesco Iorio, Serena Nik-Zainal, Graham R Bignell,[...]. Nat Commun 2014
589
12

Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
Brian J Zarnegar, Yaya Wang, Douglas J Mahoney, Paul W Dempsey, Herman H Cheung, Jeannie He, Travis Shiba, Xiaolu Yang, Wen-Chen Yeh, Tak W Mak,[...]. Nat Immunol 2008
470
11


Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
K Martin Kortüm, Elias K Mai, Nur H Hanafiah, Chang-Xi Shi, Yuan-Xiao Zhu, Laura Bruins, Santiago Barrio, Patrick Jedlowski, Maximilian Merz, Jing Xu,[...]. Blood 2016
147
11

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.
Jan Krönke, Namrata D Udeshi, Anupama Narla, Peter Grauman, Slater N Hurst, Marie McConkey, Tanya Svinkina, Dirk Heckl, Eamon Comer, Xiaoyu Li,[...]. Science 2014
990
11

Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Yutaka Okawa, Noopur Raje, Klaus Podar, Constantine Mitsiades, Nikhil C Munshi, Paul G Richardson, Ruben D Carrasco,[...]. Blood 2009
277
10

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson,[...]. Lancet Oncol 2014
10

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, T Cody Ashby, Michael Bauer, Faith Davies, Adam Rosenthal, Hongwei Wang, Pingping Qu, Antje Hoering,[...]. Leukemia 2019
205
10


MYC dysregulation in the progression of multiple myeloma.
Kristine Misund, Niamh Keane, Caleb K Stein, Yan W Asmann, Grady Day, Seth Welsh, Scott A Van Wier, Daniel L Riggs, Greg Ahmann, Marta Chesi,[...]. Leukemia 2020
69
13

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Niels Weinhold, Cody Ashby, Leo Rasche, Shweta S Chavan, Caleb Stein, Owen W Stephens, Ruslana Tytarenko, Michael A Bauer, Tobias Meissner, Shayu Deshpande,[...]. Blood 2016
138
9

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, Henk M Lokhorst, Hartmut Goldschmidt, Laura Rosinol, Paul Richardson, Simona Caltagirone, Juan José Lahuerta, Thierry Facon,[...]. J Clin Oncol 2015
9

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Niccolo Bolli, Giulia Biancon, Matahi Moarii, Silvia Gimondi, Yilong Li, Chiara de Philippis, Francesco Maura, Vijitha Sathiaseelan, Yu-Tzu Tai, Laura Mudie,[...]. Leukemia 2018
105
9

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
U Senftleben, Y Cao, G Xiao, F R Greten, G Krähn, G Bonizzi, Y Chen, Y Hu, A Fong, S C Sun,[...]. Science 2001
9

IRF4 addiction in multiple myeloma.
Arthur L Shaffer, N C Tolga Emre, Laurence Lamy, Vu N Ngo, George Wright, Wenming Xiao, John Powell, Sandeep Dave, Xin Yu, Hong Zhao,[...]. Nature 2008
486
9

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
9

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.
Gang Lu, Richard E Middleton, Huahang Sun, MarkVic Naniong, Christopher J Ott, Constantine S Mitsiades, Kwok-Kin Wong, James E Bradner, William G Kaelin. Science 2014
885
9

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.
P Leif Bergsagel, W Michael Kuehl, Fenghuang Zhan, Jeffrey Sawyer, Bart Barlogie, John Shaughnessy. Blood 2005
479
9

30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.
Qian Zhang, Michael J Lenardo, David Baltimore. Cell 2017
8

Multiple myeloma.
Antonio Palumbo, Kenneth Anderson. N Engl J Med 2011
8

Multiple myeloma clonal evolution in homogeneously treated patients.
Jill Corre, Alice Cleynen, Sébastien Robiou du Pont, Laure Buisson, Niccolo Bolli, Michel Attal, Nikhil Munshi, Hervé Avet-Loiseau. Leukemia 2018
66
12

Genomic landscape and chronological reconstruction of driver events in multiple myeloma.
Francesco Maura, Niccoló Bolli, Nicos Angelopoulos, Kevin J Dawson, Daniel Leongamornlert, Inigo Martincorena, Thomas J Mitchell, Anthony Fullam, Santiago Gonzalez, Raphael Szalat,[...]. Nat Commun 2019
119
8

Non-canonical NF-κB signaling pathway.
Shao-Cong Sun. Cell Res 2011
680
8

A critical role for the NFkB pathway in multiple myeloma.
Yulia N Demchenko, W Michael Kuehl. Oncotarget 2010
115
8

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
Jérôme Moreaux, Eric Legouffe, Eric Jourdan, Philippe Quittet, Thierry Rème, Cécile Lugagne, Philippe Moine, Jean-François Rossi, Bernard Klein, Karin Tarte. Blood 2004
400
8

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Philippe Moreau, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Ludek Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W Baker, Sharon R Jackson,[...]. N Engl J Med 2016
665
7

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
John D Shaughnessy, Fenghuang Zhan, Bart E Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, James P Stewart, Bob Kordsmeier, Christopher Randolph, David R Williams,[...]. Blood 2007
636
7

Genomic patterns of progression in smoldering multiple myeloma.
Niccolò Bolli, Francesco Maura, Stephane Minvielle, Dominik Gloznik, Raphael Szalat, Anthony Fullam, Inigo Martincorena, Kevin J Dawson, Mehmet Kemal Samur, Jorge Zamora,[...]. Nat Commun 2018
116
7

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Shaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, Joseph Mikhael, Ravi Vij, Brigitte Pegourie, Lofti Benboubker, Thierry Facon, Martine Amiot, Philippe Moreau,[...]. Blood 2017
284
7

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Pieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, Saad Usmani, David Siegel, Kenneth C Anderson, Wee-Joo Chng, Philippe Moreau, Michel Attal, Robert A Kyle,[...]. Blood 2016
492
7

The molecular classification of multiple myeloma.
Fenghuang Zhan, Yongsheng Huang, Simona Colla, James P Stewart, Ichiro Hanamura, Sushil Gupta, Joshua Epstein, Shmuel Yaccoby, Jeffrey Sawyer, Bart Burington,[...]. Blood 2006
780
7


Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
Sagar Lonial, Meletios Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Spicka, Adam Walter-Croneck, Philippe Moreau, Maria-Victoria Mateos, Hila Magen,[...]. N Engl J Med 2015
918
7

Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.
Esther A Obeng, Louise M Carlson, Delia M Gutman, William J Harrington, Kelvin P Lee, Lawrence H Boise. Blood 2006
809
7

Expanding TRAF function: TRAF3 as a tri-faced immune regulator.
Hans Häcker, Ping-Hui Tseng, Michael Karin. Nat Rev Immunol 2011
307
6

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
Eugene Varfolomeev, John W Blankenship, Sarah M Wayson, Anna V Fedorova, Nobuhiko Kayagaki, Parie Garg, Kerry Zobel, Jasmin N Dynek, Linda O Elliott, Heidi J A Wallweber,[...]. Cell 2007
971
6

Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.
Claudia Otto, Maciej Giefing, Anne Massow, Inga Vater, Stefan Gesk, Matthias Schlesner, Julia Richter, Wolfram Klapper, Martin-Leo Hansmann, Reiner Siebert,[...]. Br J Haematol 2012
63
9

Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
Sandra Gardam, Vivian M Turner, Holly Anderton, Sandhya Limaye, Antony Basten, Frank Koentgen, David L Vaux, John Silke, Robert Brink. Blood 2011
82
7

Lenalidomide after stem-cell transplantation for multiple myeloma.
Philip L McCarthy, Kouros Owzar, Craig C Hofmeister, David D Hurd, Hani Hassoun, Paul G Richardson, Sergio Giralt, Edward A Stadtmauer, Daniel J Weisdorf, Ravi Vij,[...]. N Engl J Med 2012
797
6

NF-kappa B as a therapeutic target in multiple myeloma.
Teru Hideshima, Dharminder Chauhan, Paul Richardson, Constantine Mitsiades, Nicholas Mitsiades, Toshiaki Hayashi, Nikhil Munshi, Lenny Dang, Alfredo Castro, Vito Palombella,[...]. J Biol Chem 2002
769
6

International staging system for multiple myeloma.
Philip R Greipp, Jesus San Miguel, Brian G M Durie, John J Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J Anthony Child, Herve Avet-Loiseau, Robert A Kyle,[...]. J Clin Oncol 2005
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.